Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs)
Phongthon Kanjanasiriratabc,
Kedchin Jearawuttanakulc,
Sawinee Seemakhanc,
Suparerk Borwornpinyocd,
Patompon Wongtrakoongateef,
Suradej Hongengcg and
Sitthivut Charoensutthivarakul*acf
aSchool of Bioinnovation and Bio-based Product Intelligence, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand. E-mail: sitthivut.cha@mahidol.ac.th; Tel: +66-2-201-5899
bDepartment of Pathobiology, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand
cExcellent Center for Drug Discovery (ECDD), Faculty of Science, Mahidol University, Bangkok, 10400, Thailand
dDepartment of Biotechnology, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand
eDepartment of Biochemistry, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand
fCenter for Neuroscience, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand
gDepartment of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand
First published on 18th November 2025
Abstract
Correction for ‘High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs)’ by Phongthon Kanjanasirirat et al., RSC Adv., 2025, 15, 12331–12341, https://doi.org/10.1039/D5RA01341K.
The authors regret the omission of Tanawadee Khumpanied from the Acknowledgements. The correct Acknowledgements are as shown here.
This research was partially supported by the Ramathibodi Foundation and Thailand Center of Excellence for Life Sciences (TCELS), and also by the Faculty of Science, Mahidol University via the Reinventing University Project. The authors would like to thank Dr Witchuda Saengsawang, Dr Jiraporn Panmanee and Dr Sujira Mukda for discussions and Ms Tanawadee Khumpanied for preliminary data collection.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2025 |